Mechanisms of evasion to antiangiogenic therapy in glioblastoma
Rose, S.D.; Aghi, M.K.
Clinical Neurosurgery 57: 123-128
2010
ISSN/ISBN: 0069-4827 PMID: 21280504 Document Number: 640607
Document emailed within 1 workday
Related Documents
Tzerkovsky, D.A.; Osharin, V.V.; Istomin, Y.P.; Alexandrova, E.N.; Vozmitel, M.A. 2014: Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models Experimental Oncology 36(2): 85-89Browder, T.; Folkman, J.; Hahnfeldt, P.; Heymach, J.; Hlatky, L.; Kieran, M.; Rogers, M.S. 2002: Antiangiogenic therapy and p53 Science 297(5581): 471; discussion 471
Davidson, G.S. 2005: Compounding antiangiogenic cancer therapy for animals International Journal of Pharmaceutical Compounding 9(3): 195-198
Wu, X.Z. 2008: New strategy of antiangiogenic therapy for hepatocellular carcinoma Neoplasma 55(6): 472-481
Mamikonian, V.R.; Voevodina, T.M.; Fedorov, A.A.; Budzinskaia, M.V.; Balaian, M.L. 2013: Experimental and morphological study of the effect of antiangiogenic therapy on corneal neovessels Vestnik Oftalmologii 129(6): 45-50
Gennari, L.; Belinsky, J.; Graziano, C.; Jankilevich, G. 2011: Hypertension as predictive factor in renal cell cancer treated with antiangiogenic therapy Medicina 71(3): 207-210
Schultheis, B.; Kummer, G.; Tannapfel, A.; Strumberg, D. 2010: Successful sequential antiangiogenic therapy for alveolar soft part sarcoma - a case report International Journal of Clinical Pharmacology and Therapeutics 48(7): 468-469
Aoki, Y.; Morita, S.; Arai, T.; Kurusu, A.; Tsunemoto, H. 1982: Fast neutron therapy for glioblastoma multiforme (astrocytoma grade IV) Gan no Rinsho. Japan Journal of Cancer Clinics 28(3): 181-185
Ng, K.; Nitta, M.; Hu, L.; Kesari, S.; Kung, A.; D'Andrea, A.; Chen, C.C. 2009: A small interference RNA screen revealed proteasome inhibition as strategy for glioblastoma therapy Clinical Neurosurgery 56: 107-118
Dorn, R.V.; Spickard, J.H.; Griebenow, M.L. 1989: A proposed protocol for clinical trials of boron neutron capture therapy in glioblastoma multiforme Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 233-234
Linassier, C.; Benboubker, L.; Velut, S.; Calais, G.; Saudeau, D.; Jan, M.; Autret, A.; Berger, C.; Biron, P.; Colombat, P. 1996: High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme Bone Marrow Transplantation 18(Suppl 1): S69-S72
Terry, R.J.; Smithers, S.R. 1975: Evasion of the immune response by parasites Symposia of the Society for Experimental Biology 29: 453-465
Glover, D. 2004: Complaints require action not evasion Journal of Wound Care 13(9): 351
Caputi, M.; Esposito, V.; Groger, A.M.; De Luca, A.; Pacilio, C.; Dekan, G.; Giordano, G.G.; Baldi, F.; Wolner, E.; Giordano, A. 1998: RB growth control evasion in lung cancer Anticancer Research 18(4a): 2371-2374
Li, V.W.; Li, W.W.; Talcott, K.E.; Zhai, A.W. 2005: Imiquimod as an antiangiogenic agent Journal of Drugs in Dermatology: Jdd 4(6): 708-717
Saijo, N. 2010: Treatment with antiangiogenic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 68(6): 1007-1013
Shchelkunov, S.N. 2011: Evasion of mammalian organism defense systems by orthopoxviruses Molekuliarnaia Biologiia 45(1): 30-43
Lafon, M. 2008: Immune evasion, a critical strategy for rabies virus Developments in Biologicals 131: 413-419
Ren, B.; Höti, N.; Rabasseda, X.; Wang, Y-Z.; Wu, M. 2003: The antiangiogenic and therapeutic implications of endostatin Methods and Findings in Experimental and Clinical Pharmacology 25(3): 215-224
Shin, S.; Muñoz, M.; Zeladita, J.; Slavin, S.; Caldas, A.; Sanchez, E.; Callacna, M.; Rojas, C.; Arevalo, J.; Sebastian, J.L.; Bayona, J. 2011: How does directly observed therapy work? the mechanisms and impact of a comprehensive directly observed therapy intervention of highly active antiretroviral therapy in Peru Health and Social Care in the Community 19(3): 261-271